Results

Total Results: 1,534 records

Showing results for "drug".

321. Helping to Answer Pressing Policy Questions with Data and Analytics | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/news/blog/ahrqviews/answer-policy-questions-data.html
     March 01, 2021 - decisions on critical issues ranging from expanding access to health insurance to lowering prescription drug … ACA-related issues pertaining to coverage gaps, uneven subsidies, and premium assistance Prescription drug

322. Patient Safety Organizations: A Summary of 2014 Profiles (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/npsd/npsd-portfolios-summary-profile-2014.pdf
     January 01, 2014 - Evaluation of perioperative medication errors and adverse drug events. … As a result of the standardization effort, 470 unique formulations for 147 drug entities were reduced … Pharmacy Standard Resulting From Collaboration: Rifampin Suspension Example Drug name: Concentration

323. Opioids AHRQ Works: Building Bridges Between Research and Practice (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/topics/impact-opioid-final.pdf
     November 01, 2018 - Opioids AHRQ Works: Building Bridges Between Research and Practice Opioids Deaths from drug

324. Comparative Health System Performance Initiative: National Bureau of Economic Research Center of Excellence | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/chsp/about-chsp/centers/nber.html
     July 01, 2019 - An examination of the effects of the 340B Drug Pricing Program on hospital–physician consolidation and

325. AHRQ National Scorecard on Hospital-Acquired Conditions: Final Results for 2014 Through 2017 (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/Updated-hacreportFInal2017data.pdf
     July 01, 2020 - 28 measures of patient safety events, including many types of hospital-acquired infections, adverse drug … For example, measured adverse drug events continued to drop from 2014 to 2017, while measured pressure … Central Line-Associated Bloodstream Infections Catheter-Associated Urinary Tract Infections Adverse Drug … of HACs 2017 Normalized Count of HACs Percent Change in HACs, 2014 vs. 2017 Adverse Drug … Measures used to estimate the national HAC rate HAC Type Source Measure Adverse Drug Event MPSMS

326. Search Evidence-Based Reports | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/research/findings/evidence-based-reports/search.html?page=23
     June 01, 2012 - Type: Comparative Effectiveness Reviews Affiliation: Minnesota EPC Report Status: Final Drug … Comparative Effectiveness Reviews Affiliation: Johns Hopkins University Report Status: Final Drug

327. Safemed Facguide (doc file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.docx
     May 01, 2017 - Having uniform and standard drug packaging, preparation, and labeling.

328. Staff Training Instructor Guide | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/teamstepps/lep/traintrainers/lepigstafftrain.html
     October 01, 2020 - The ER physician, who did not speak Spanish, assumed Willie had a drug overdose because he had pinpoint … When the ER doctor told the family he would treat Willie for drug overdose, they said to one another, … And the nurse said, 'You said you're not allergic to medicine....drug or latex.'

329. TeamSTEPPS Specialty Scenarios: Ancillary Services (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/teamstepps/instructor/scenarios/ancillary.pdf
     March 19, 2014 - It is not noted that one of the meds received is a new generic form of a brand drug just added to the … The Pharmacy is currently out of the brand drug, and unaware that this was a replacement drug, the day … During the change between shifts, the night crew is informed of the new drug derivative so that there … Clara, an experienced pharmacy technician, questions the drug dosage. Dr.

330. “Near-miss” Reporting System Development and Implications for Human Subjects Protection (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Murff.pdf
     January 01, 2004 - In protocol A, the agent is an investigational drug; in protocol B, the agent is an approved drug and … The pharmacist inadvertently prepared an incorrect concentration of a study infusion drug. … This medication error was detected by a staff nurse prior to drug administration. … Investigational drug service pharmacists might also be suited to identify these problems. … Systems analysis of adverse drug events. ADE Prevention Study Group.

331. Identifying, Understanding, and Communicating Medical Device Use Errors: Observations from an FDA Pilot Program (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Flack.pdf
     January 01, 2005 - Food and Drug Administration (FDA) attempts to identify and understand new risks associated with medical … Food and Drug Administration (FDA) has been working collaboratively with a relatively small, well-trained … Building a new reporting system The Federal Food, Drug and Cosmetic Act (the Act), Section 519, mandates … when Congress in 1997 modified the legislation dealing with user facility reporting in the Food and Drug … Federal Food, Drug and Cosmetic Act, February 1998; Section 519: pp. 206–210. 2.

332. CAHPS Cancer Care Supplemental Items (doc file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/suppl-items-cancer-access-english-557-1a.docx
     March 07, 2017 - the bracketed references to [CANCER TREATMENT MODALITY] with the appropriate term: radiation therapy, drug

333. Chartbook on Hispanic Health Care: Slide Presentation—Part 2 | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/research/findings/nhqrdr/2014chartbooks/hispanichealth/hisph-slides-pt2.html
     May 01, 2018 - Results from the 1983 single-room occupancy hotels study of drug abuse in New York City suggest that … in the last 12 months Same No Change People age 12 and over who needed treatment for illicit drug … Slide 23 People age 12 and over who needed treatment for illicit drug use or an alcohol problem and … Note: Treatment refers to treatment at a specialty facility, such as a drug and alcohol inpatient and … Overall Rate: In 2012, only 10.8% of people age 12 and over who needed treatment for illicit drug use

334. Value Set Export (xls file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085behaviorcoding.xls
     January 01, 2012 - FFS PHDSC 2.16.840.1.113883.221.5 Payer Individual Characteristic Source of Payment Typology 4.0 122 Drug … Improvement(R) (AMA-PCPI) 2.16.840.1.113883.3.526.3.1363 Illicit, Prescription and Over the Counter Drug … /Assessment GROUPING n/a 2.16.840.1.113883.3.526.2.1445 "Illicit, Prescription and Over the Counter Drug … Improvement(R) (AMA-PCPI) 2.16.840.1.113883.3.526.2.1445 Illicit, Prescription and Over the Counter Drug … Use Screening Risk Category/Assessment LOINC 2.38 68526-3 Do you abuse more than one drug at a time

335. Tool: I'M SAFE Checklist | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/teamstepps-program/curriculum/situation/tools/safe.html
     June 01, 2023 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

336. Learn From Defects Tool Worksheet: Central Line-Assoiated Bloodstsream Infection (CLABSI) (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/clabsi-learning-from-defects.pdf
     April 01, 2022 - Learn From Defects Tool Worksheet: Central Line-Assoiated Bloodstsream Infection (CLABSI) AHRQ Safety Progr…

337. Table 3a. Examples of Evaluation Measures for Self-management Support Programs for Common Chronic Conditions | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/research/findings/final-reports/ptmgmt/evaluation-table3a.html
     July 01, 2018 - Prescription drug purchase/refills (e.g., beta agonists, inhaled corticosteroids, leukotrine modifiers

338. Pediatric Patient Safety Consortium (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA202-Materials_XIII.pdf
     January 01, 2014 - Please provide documentation of the item's current classification by the Food and Drug Administration … Identify the Item (product or drug/biological) for which a Level II HCPCS Code is being requested. … A) Trade or Brand Name: B) General Product Name or Generic Drug Name (active ingredient): C) FDA … (If a drug - list other drugs by trade name marketed under the same active ingredient category/generic … For drugs and biologicals only: In order for an application for a code for a drug/biological can be

339. Pediatric Patient Safety Consortium (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIII.pdf
     August 25, 2014 - Please provide documentation of the item's current classification by the Food and Drug Administration … Identify the Item (product or drug/biological) for which a Level II HCPCS Code is being requested. … A) Trade or Brand Name: B) General Product Name or Generic Drug Name (active ingredient): C) FDA … (If a drug - list other drugs by trade name marketed under the same active ingredient category/generic … For drugs and biologicals only: In order for an application for a code for a drug/biological can be

340. Pediatric Patient Safety Consortium (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIII.pdf
     August 13, 2014 - Please provide documentation of the item's current classification by the Food and Drug Administration … Identify the Item (product or drug/biological) for which a Level II HCPCS Code is being requested. … A) Trade or Brand Name: B) General Product Name or Generic Drug Name (active ingredient): C) FDA … (If a drug - list other drugs by trade name marketed under the same active ingredient category/generic … For drugs and biologicals only: In order for an application for a code for a drug/biological can be